Medication info
Neomaryl M Tablet 2/500 mg

Neomaryl M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201107219 · Approved 2011.09.27 · Insurance code 643306130

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels through the combination of Glymepride and Metformin. When taken alongside diet and exercise, it can effectively improve blood sugar levels, thereby facilitating better blood sugar management and contributing to the prevention of diabetes-related complications.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be temporarily discontinued when kidney function declines sharply or dehydration is present. Moreover, it should not be administered to patients with a kidney function below 45 mL/min/1.73 m2, those with severe liver dysfunction, or pregnant and nursing women. While this medication helps with blood sugar control, hypoglycemic symptoms may occur, so special caution is needed for the elderly, malnourished patients, or those with irregular eating habits. Initially, gastrointestinal disturbances such as diarrhea, nausea, and vomiting may commonly occur, and these symptoms usually improve naturally over time. Lactic acidosis is a very rare side effect but can be fatal; thus, if symptoms such as muscle pain, weakness, or difficulty breathing occur, immediate medical attention should be sought. This medication can interact with other drugs, so it is essential to inform the doctor or pharmacist of any other medications you are taking. Regular monitoring of blood sugar control is necessary, and there is a risk of vitamin B12 deficiency, so blood tests may be needed for monitoring. In case of overdose, there is a risk of hypoglycemia or lactic acidosis; therefore, it is important to adhere to the prescribed dosage and visit a medical facility immediately if any abnormal symptoms arise. Caution is required when driving or operating machinery, as symptoms of hypoglycemia or dizziness may occur. The safety and efficacy of this medication in children have not been sufficiently established; therefore, special caution is needed when administering it to pediatric patients.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 82 more
  • discomfort
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • urticaria
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • erythrocytopenia
  • agranulocytosis
  • pancytopenia
  • decrease in vitamin B12
  • peripheral neuropathy
  • increased liver enzymes
  • liver dysfunction
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency during diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal distension
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal cancer
  • dizziness
  • liver dysfunction
  • arthralgia
  • facial edema
  • erectile dysfunction
  • facial flushing
  • gastritis
  • headache
  • extreme hunger
  • fatigue
  • sleep
  • weakness
  • drowsiness
  • sleep disorders
  • instability
  • aggression
  • concentration deficit
  • inability to focus
  • abnormal reactions
  • feelings of depression
  • confusion
  • language impairment
  • aphasia
  • tremors
  • paralysis
  • sensory disturbances
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral convulsions
  • loss of consciousness
  • coma
  • weak breathing
  • slow pulse
  • sweating
  • clammy skin
  • anxiety
  • rapid pulse
  • hypertension
  • palpitations
  • angina pectoris
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture exposure. It is best to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.